Lars Lykke Thomsen

Years Active: 2023-2023
Publications (10 Years): 1

This page only lists publications with an associated author ORCID identifier.

Publications

Margaret Haney, Monique Vallée, Sandy Fabre, Stephanie C Reed, Marion Zanese, Ghislaine Campistron, Caroline A Arout, Richard W Foltin, Ziva D Cooper, Tonisha Kearney-Ramos, Mathilde Metna, Zuzana Justinova, Charles W Schindler, Etienne Hebert-Chatelain, Luigi Bellocchio, Adeline Cathala, Andrea Bari, Roman Serrat, David B Finlay, Filippo Caraci, Bastien Redon, Elena Martin Garcia, Arnau Busquets-Garcia, Isabelle Matias, Frances R Levin, François-Xavier Felpin, Nicolas Simon, Daniela Cota, Umberto Spampinato, Rafael Maldonado, Yavin Shaham, Michelle Glass, Lars Lykke Thomsen, Helle Mengel, Giovanni Marsicano, Stéphanie Monlezun, Jean-Michel Revest, Pier Vincenzo Piazza
Signaling-specific inhibition of the CB 1 receptor for cannabis use disorder: phase 1 and phase 2a randomized trials. Nature medicine (2023)

Lars Lykke Thomsen.css-eqlu8i{font-size:small;padding-left:4px;}